€5.93
2.83% day before yesterday
L&S, Jun 28, 10:54 pm CET
ISIN
US7458481014
Symbol
LUNG

ProLung Inc Target price 2024 - Analyst rating & recommendation

ProLung Inc Classifications & Recommendation:

Buy
83%
Hold
17%

ProLung Inc Target price

Target price $14.83
Course $6.34
Price potential
Number of estimates 6
6 Analysts have issued a price target ProLung Inc 2025 . The average ProLung Inc target price is $14.83. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 5 Analysts recommend ProLung Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the ProLung Inc share has an average upside potential 2025 of . Most analysts recommend the ProLung Inc share at Purchase.

Sales and margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 68.68 82.59
27.99% 20.26%
EBITDA margin -87.35% -63.13%
14.22% 27.73%
Net margin -90.41% -83.17%
21.38% 8.01%

6 Analysts have issued a sales forecast ProLung Inc 2024 . The average ProLung Inc sales estimate is

$82.6m
unlock
. This is
13.16% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$83.5m 14.44%
unlock
, the lowest is
$81.0m 10.97%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $68.7m 27.99%
2024
$82.6m 20.26%
unlock
2025
$98.2m 18.86%
unlock
2026
$118m 20.36%
unlock
2027
$144m 21.61%
unlock

6 Analysts have issued an ProLung Inc EBITDA forecast 2024. The average ProLung Inc EBITDA estimate is

$-52.1m
unlock
. This is
9.59% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-38.8m 32.72%
unlock
, the lowest is
$-64.4m 11.67%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-60.0m 9.79%
2024
$-52.1m 13.09%
unlock
2025
$-47.3m 9.24%
unlock
2026
$-36.9m 22.01%
unlock
2027
$8.2m 122.22%
unlock

EBITDA margin

2023 -87.35% 14.22%
2024
-63.13% 27.73%
unlock
2025
-48.20% 23.65%
unlock
2026
-31.23% 35.21%
unlock
2027
5.71% 118.28%
unlock

1 Analyst has issued a net profit forecast ProLung Inc 2024 . The average ProLung Inc net profit estimate is

$-68.7m
unlock
. This is
14.93% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-68.7m 14.93%
unlock
, the lowest is
$-68.7m 14.93%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-62.1m 0.63%
2024
$-68.7m 10.62%
unlock
2025
$-63.7m 7.34%
unlock
2026
$-46.2m 27.45%
unlock
2027
$-29.1m 36.96%
unlock

Net margin

2023 -90.41% 21.38%
2024
-83.17% 8.01%
unlock
2025
-64.83% 22.05%
unlock
2026
-39.09% 39.70%
unlock
2027
-20.26% 48.17%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -1.60 -1.77
0.63% 10.63%
P/E ratio negative
EV/Sales 2.06

1 Analysts have issued a ProLung Inc forecast for earnings per share. The average ProLung Inc <a href=/blog/eps>EPS is

$-1.77
unlock
. This is
14.94% lower
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-1.77 14.94%
unlock
, the lowest is
$-1.77 14.94%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-1.60 0.63%
2024
$-1.77 10.63%
unlock
2025
$-1.64 7.34%
unlock
2026
$-1.19 27.44%
unlock
2027
$-0.75 36.97%
unlock

P/E ratio

Current -4.13 51.41%
2024
-3.58 13.32%
unlock
2025
-3.87 8.10%
unlock
2026
-5.33 37.73%
unlock
2027
-8.45 58.54%
unlock

Based on analysts' sales estimates for 2024, the ProLung Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 2.33 64.48%
2024
2.06 11.51%
unlock
2025
1.73 15.87%
unlock
2026
1.44 16.91%
unlock
2027
1.19 17.78%
unlock

P/S ratio

Current 3.37 60.19%
2024
2.98 11.63%
unlock
2025
2.51 15.87%
unlock
2026
2.08 16.91%
unlock
2027
1.71 17.78%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now